Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-CARE: Denosumab as Adjuvant Treatment in High-Risk Early Breast Cancer
jRCT2080221128Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Denosumab arm with Placebo arm (2 arms). Started Jun 2010; status: completed.
02
Drugs
denosumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080221128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221128.